1. Home
  2. ASPN vs MDXG Comparison

ASPN vs MDXG Comparison

Compare ASPN & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASPN
  • MDXG
  • Stock Information
  • Founded
  • ASPN 2001
  • MDXG 2006
  • Country
  • ASPN United States
  • MDXG United States
  • Employees
  • ASPN N/A
  • MDXG N/A
  • Industry
  • ASPN RETAIL: Building Materials
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASPN Consumer Discretionary
  • MDXG Health Care
  • Exchange
  • ASPN Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • ASPN 948.5M
  • MDXG 1.3B
  • IPO Year
  • ASPN 2014
  • MDXG N/A
  • Fundamental
  • Price
  • ASPN $11.62
  • MDXG $8.57
  • Analyst Decision
  • ASPN Strong Buy
  • MDXG Strong Buy
  • Analyst Count
  • ASPN 10
  • MDXG 5
  • Target Price
  • ASPN $30.00
  • MDXG $12.00
  • AVG Volume (30 Days)
  • ASPN 1.5M
  • MDXG 617.6K
  • Earning Date
  • ASPN 02-12-2025
  • MDXG 02-26-2025
  • Dividend Yield
  • ASPN N/A
  • MDXG N/A
  • EPS Growth
  • ASPN N/A
  • MDXG N/A
  • EPS
  • ASPN 0.02
  • MDXG 0.52
  • Revenue
  • ASPN $413,830,000.00
  • MDXG $342,804,000.00
  • Revenue This Year
  • ASPN $92.45
  • MDXG $9.56
  • Revenue Next Year
  • ASPN $10.38
  • MDXG $9.19
  • P/E Ratio
  • ASPN $581.34
  • MDXG $16.49
  • Revenue Growth
  • ASPN 93.28
  • MDXG 10.93
  • 52 Week Low
  • ASPN $10.67
  • MDXG $5.47
  • 52 Week High
  • ASPN $33.15
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • ASPN 42.22
  • MDXG 41.31
  • Support Level
  • ASPN $10.79
  • MDXG $8.29
  • Resistance Level
  • ASPN $12.18
  • MDXG $9.30
  • Average True Range (ATR)
  • ASPN 0.62
  • MDXG 0.30
  • MACD
  • ASPN 0.05
  • MDXG -0.04
  • Stochastic Oscillator
  • ASPN 36.21
  • MDXG 27.10

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: